Memory Support System for Older Chinese Americans With Mild Cognitive Impairment (NCT07142499)
A Pilot of Memory Support System for Older Chinese Americans With Mild Cognitive Impairment
๐ฉบ Plain-English Summary (8th-Grade Level)
The Memory Support System (MSS) from the Healthy Action to Benefit Independence \& Thinkingยฎ (HABIT) Program is an evidence-based, non-pharmacological intervention for mild cognitive impairment (MCI). Despite the clinical benefits and feasibility, the MSS was primarily developed and used with non-Hispanic White, English-speaking adults. Racial/ethnic minority groups are chronically under-enrolled in clinical trials for Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) due to lack of linguistically and culturally appropriate adaptation of assessment measures and intervention protocols. The purpose of this research study is to examine whether the MSS from HABIT can help Chinese American older adults with mild thinking and memory problems. Target recruitment is 60 Chinese American adults who are primarily Mandarin- (n=30) and Cantonese-speaking (n=30). Forty participants will participate in the trainer-led day planner training and 20 will participate in self-study of the day planner and receive brain health education. Each participant will also be asked to identify a study partner to participate with them.
Who can join: Review the eligibility criteria below.
Location: Li Lab, Icahn School of Medicine at Mount Sinai โ New York, New York
Age range: 55 Years
๐งช Interventions in This Study
- Memory Support System (BEHAVIORAL)
- Brain Health Education (BEHAVIORAL)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Li Lab, Icahn School of Medicine at Mount Sinai โ New York, New York
๐ Contact the Study Coordinator
Phone: (212) 585-4631
Email: clara.li@mssm.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Mild Cognitive Impairment (MCI)
- Wearable Sensor for Early Detection and Monitoring of Cognitive Decline โ Los Angeles, California
- Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers โ La Jolla, California
- AI-CONECT: A Conversational AI for Early Dementia Prevention in Socially-Isolated Older Adults โ Boston, Massachusetts
- Assessing Treatment With High-phenolic EVOO Supplements for Neurovascular Activity โ Augusta, Georgia
- An Insole and Ankle Device for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) โ Saint Paul, Minnesota
- Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device. โ Palisades Park, New Jersey
Explore by condition: All Mild Cognitive Impairment (MCI) clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.